Science Explorer Back to mapMap

Most cited papers from Infectious Diseases Data Observatory

Infectious Diseases Data Observatory

What are the most cited papers from Infectious Diseases Data Observatory?

The most cited paper from Infectious Diseases Data Observatory is "Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study" (Annemarie Beth Docherty et al., 2020), with 3,647 citations. Next come "Corticosteroid Therapy for Critically Ill Patients with Middle East Respiratory Syndrome" (1,208) and "Mapping the global prevalence, incidence, and mortality of Plasmodium falciparum, 2000–17: a spatial and temporal modelling study" (520).

Showing 50 of 61 papers. Every paper with more than 32 citations is listed.

Most cited papers, sortable by citations and release date
#Paper
1 Features of 20 133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study Annemarie Beth Docherty et al. · BMJ Open access 22 May 2020 3,647
2 Corticosteroid Therapy for Critically Ill Patients with Middle East Respiratory Syndrome Yaseen M. Arabi et al. · American Journal of Respiratory and Critical Care Medicine 21 Nov 2017 1,208
3 Mapping the global prevalence, incidence, and mortality of Plasmodium falciparum, 2000–17: a spatial and temporal modelling study Daniel J. Weiss et al. · The Lancet Open access 19 Jun 2019 520
4 Mapping the global endemicity and clinical burden of Plasmodium vivax, 2000–17: a spatial and temporal modelling study Katherine E. Battle et al. · The Lancet Open access 19 Jun 2019 434
5 Features of 16,749 hospitalised UK patients with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol AB Docherty et al. · medRxiv PreprintOpen access 28 Apr 2020 395
6 Artemisinin-resistant Plasmodium falciparum in Pursat province, western Cambodia: a parasite clearance rate study Chanaki Amaratunga, Sokunthea Sreng, Seila Suon et al. · The Lancet Infectious Diseases Open access 29 Aug 2012 360
7 Long Covid in adults discharged from UK hospitals after Covid-19: A prospective, multicentre cohort study using the ISARIC WHO Clinical Characterisation Protocol Louise Sigfrid et al. · The Lancet Regional Health - Europe Open access 6 Aug 2021 326
8 Enumerating the economic cost of antimicrobial resistance per antibiotic consumed to inform the evaluation of interventions affecting their use Poojan Shrestha, Ben Symons Cooper, Joanna Coast et al. · Antimicrobial Resistance and Infection Control Open access 9 Aug 2018 296
9 The Threat of Artemisinin-Resistant Malaria Arjen M. Dondorp, Rick M. Fairhurst, Laurence Slutsker et al. · New England Journal of Medicine Open access 21 Sep 2011 279
10 Ribavirin and Interferon Therapy for Critically Ill Patients With Middle East Respiratory Syndrome: A Multicenter Observational Study Yaseen M. Arabi et al. · Clinical Infectious Diseases Open access 25 Jun 2019 257
11 Critically Ill Patients With the Middle East Respiratory Syndrome: A Multicenter Retrospective Cohort Study Yaseen M. Arabi et al. · Critical Care Medicine 5 Aug 2017 196
12 COVID-19 and risks to the supply and quality of tests, drugs, and vaccines Paul N. Newton et al. · The Lancet Global Health Open access 9 Apr 2020 169
13 Noninvasive ventilation in critically ill patients with the Middle East respiratory syndrome Basem M. Alraddadi et al. · Influenza and Other Respiratory Viruses Open access 18 Mar 2019 134
14 Macrolides in critically ill patients with Middle East Respiratory Syndrome Yaseen M. Arabi et al. · International Journal of Infectious Diseases Open access 27 Jan 2019 126
15 Microbiology Investigation Criteria for Reporting Objectively (MICRO): a framework for the reporting and interpretation of clinical microbiology data Paul Turner, Andrew Fox‐Lewis, Poojan Shrestha et al. · BMC Medicine Open access 28 Mar 2019 110
16 Field detection devices for screening the quality of medicines: a systematic review Serena Vickers, Matthew C. Bernier, Stephen C. Zambrzycki et al. · BMJ Global Health ReviewOpen access Aug 2018 99
17 Host immunity to Plasmodium falciparum and the assessment of emerging artemisinin resistance in a multinational cohort Ricardo Ataíde et al. · Proceedings of the National Academy of Sciences Open access 13 Mar 2017 95
18 Precision global health in the digital age Antoine Flahault, Antoine Geissbühler, Idris Guessous et al. · Swiss Medical Weekly Open access 8 Apr 2017 92
19 Evaluating drug resistance in visceral leishmaniasis: the challenges Sarah Hendrickx, Philippe Jean Guerin, Guy Caljon et al. · Parasitology Open access 21 Nov 2016 89
20 Avoiding Data Dumpsters — Toward Equitable and Useful Data Sharing Laura Merson, Oumar Gaye, Philippe Jean Guerin · New England Journal of Medicine Open access 11 May 2016 89
21 Beyond open data: realising the health benefits of sharing data: Table 1 Elizabeth Pisani, Peter Aaby, J. Gabrielle Breugelmans et al. · BMJ Open access 10 Oct 2016 86
22 Clinical impact of vivax malaria: A collection review Aung Pyae Phyo, Prabin Dahal, Mayfong Mayxay et al. · PLoS Medicine Open access 18 Jan 2022 84
23 Non-malarial febrile illness: a systematic review of published aetiological studies and case reports from Southern Asia and South-eastern Asia, 1980–2015 Poojan Shrestha, Prabin Dahal, Chinwe Ogbonnaa-Njoku et al. · BMC Medicine ReviewOpen access 20 Sep 2020 81
24 Substandard and falsified antibiotics: neglected drivers of antimicrobial resistance? Guillermo A Zabala, Khonsavath Bellingham, Vayouly Vidhamaly et al. · BMJ Global Health Open access Aug 2022 80
25 Vertebrate population trends are influenced by interactions between land use, climatic position, habitat loss and climate change Jessica J. Williams, Robin Freeman, Fiona E. B. Spooner et al. · Global Change Biology Open access 26 Nov 2021 78
26 A systematic review and an individual patient data meta-analysis of ivermectin use in children weighing less than fifteen kilograms: Is it time to reconsider the current contraindication? Podjanee Jittamala et al. · PLoS neglected tropical diseases ReviewOpen access 17 Mar 2021 78
27 Characteristics and outcomes of an international cohort of 600 000 hospitalized patients with COVID-19 Christiana Kartsonaki et al. · International Journal of Epidemiology Open access1,655 authors 28 Feb 2023 76
28 An inventory of supranational antimicrobial resistance surveillance networks involving low- and middle-income countries since 2000 Elizabeth A. Ashley, Judith Recht, Arlene Chua et al. · Journal of Antimicrobial Chemotherapy Open access 13 Jan 2018 76
29 Febrile illness in Asia: gaps in epidemiology, diagnosis and management for informing health policy Poojan Shrestha, Tamalee Roberts, Anousin Homsana et al. · Clinical Microbiology and Infection Open access 23 Mar 2018 76
30 The consequence of COVID-19 on the global supply of medical products: Why Indian generics matter for the world? Philippe Jean Guerin, Sauman Singh-Phulgenda, Nathalie Strub Wourgaft · F1000Research Open access Apr 2020 74
31 Identifying Ideologues: A Global Dataset on Political Leaders, 1945–2020 Bastian Herre · British Journal of Political Science 6 Jul 2022 72
32 Effect of primaquine dose on the risk of recurrence in patients with uncomplicated Plasmodium vivax: a systematic review and individual patient data meta-analysis Robert James Commons et al. · The Lancet Infectious Diseases ReviewOpen access 22 Sep 2023 68
33 Non-malarial febrile illness: a systematic review of published aetiological studies and case reports from Africa, 1980–2015 Jeanne Elven, Prabin Dahal, Elizabeth A. Ashley et al. · BMC Medicine ReviewOpen access 20 Sep 2020 65
34 A living systematic review protocol for COVID-19 clinical trial registrations Brittany Maguire, Philippe Jean Guerin · Wellcome Open Research ReviewOpen access 2 Apr 2020 60
35 Efficacy of Single-Dose Primaquine With Artemisinin Combination Therapy on Plasmodium falciparum Gametocytes and Transmission: An Individual Patient Meta-Analysis Kasia Stepniewska et al. · The Journal of Infectious Diseases Open access 6 Aug 2020 59
36 Global access to quality-assured medical products: the Oxford Statement and call to action Paul N. Newton et al. · The Lancet Global Health Open access161 authors 7 Nov 2019 58
37 Field evaluation of the diagnostic performance of EasyScan GO: a digital malaria microscopy device based on machine-learning Debashish Das et al. · Malaria Journal Open access 12 Apr 2022 56
38 Global estimation of anti-malarial drug effectiveness for the treatment of uncomplicated Plasmodium falciparum malaria 1991–2019 Giulia Rathmes et al. · Malaria Journal Open access 20 Oct 2020 56
39 Secondary analysis and participation of those at the data source Laura Merson, Philippe Jean Guerin, Karen Irma Barnes et al. · The Lancet Global Health Open access 10 Aug 2018 56
40 Spatiotemporal spread of Plasmodium falciparum mutations for resistance to sulfadoxine-pyrimethamine across Africa, 1990–2020 Jennifer A. Flegg, Georgina S. Humphreys, Brenda Montanez et al. · PLoS Computational Biology Open access 11 Aug 2022 55
41 Pregnancy outcomes after first-trimester treatment with artemisinin derivatives versus non-artemisinin antimalarials: a systematic review and individual patient data meta-analysis Makoto Saito et al. · The Lancet ReviewOpen access 25 Nov 2022 54
42 Primaquine dose and the risk of haemolysis in patients with uncomplicated Plasmodium vivax malaria: a systematic review and individual patient data meta-analysis Megha Rajasekhar et al. · The Lancet Infectious Diseases ReviewOpen access 22 Sep 2023 45
43 The uncertain role of substandard and falsified medicines in the emergence and spread of antimicrobial resistance Sean Cavany, Stella Maris Nanyonga, Cathrin Hauk et al. · Nature Communications Open access 3 Oct 2023 44
44 Cancer Mortality Patterns in Tanzania: A Retrospective Hospital-Based Study, 2006-2015 Emanuel P. Lyimo, Susan F. Rumisha, Irene R. Mremi et al. · JCO Global Oncology Open access 19 Feb 2020 44
45 Preprints in times of COVID19: the time is ripe for agreeing on terminology and good practices Raffaella Ravinetto, Céline Caillet, Muhammad Hamid Zaman et al. · BMC Medical Ethics Open access 28 Jul 2021 43
46 Factors affecting the electrocardiographic QT interval in malaria: A systematic review and meta-analysis of individual patient data Xin Hui S Chan et al. · PLoS Medicine ReviewOpen access 5 Mar 2020 41
47 Mapping genetic markers of artemisinin resistance in Plasmodium falciparum malaria in Asia: a systematic review and spatiotemporal analysis Frank M Kagoro, Karen I Barnes, Kevin Marsh et al. · The Lancet Microbe ReviewOpen access 25 Jan 2022 40
48 Efficacy and tolerability of artemisinin-based and quinine-based treatments for uncomplicated falciparum malaria in pregnancy: a systematic review and individual patient data meta-analysis Makoto Saito et al. · The Lancet Infectious Diseases ReviewOpen access 29 Apr 2020 40
49 Multiple HIV-1/M + HIV-1/O dual infections and new HIV-1/MO inter-group recombinant forms detected in Cameroon Fabienne De Oliveira, Thomas Mourez, Aurélia Vessière et al. · Retrovirology Open access 13 Jan 2017 40
50 Systematic review of the diagnosis and management of necrotising otitis externa: Highlighting the need for high‐quality research Junko Takata, Michael Edward Hopkins, Victoria Alexander et al. · Clinical Otolaryngology ReviewOpen access 9 Feb 2023 38

Citations are OpenAlex's own counts, from its 2026-09-23 snapshot, so the ranking can differ from Google Scholar or Web of Science. A paper is listed for an institution when any of its authors gave it as an affiliation; retracted papers and papers whose citation count cannot be traced to citing works are left out, and a preprint and the article it became are shown once. Release dates are OpenAlex's: where a source gave only a month or a year, that is what is shown. How the lists are chosen.